Nancy Lee is an Oncology physician. ClinicalTrials.gov lists 17 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4650 Palm Ave
San Diego, CA 921548404
Telephone
877-236-0333Registry record last updated 6 Dec 2021.
Clinical trials
- A Study of Cemiplimab and Fianlimab in People With Nasopharyngeal Carcinoma
Sponsor: Memorial Sloan Kettering Cancer Center
- A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
- A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
65.5%Cytochrome P450 17A1 Inhibitor23.2%Abiraterone Acetate100%Part D≥80 patientsAromatase Inhibitor22.7%Anastrozole79%Letrozole17%Exemestane4%Part D<11 patients+ 6 more classes in this area
Metabolism & gastrointestinal
21%Corticosteroid13.6%Prednisone100%Part D≥84 patientsSerotonin-3 Receptor Antagonist4.7%Ondansetron Hcl100%Part D≥51 patients+ 1 more class in this area
Nervous system
4.6%Gabapentinoids1.7%Gabapentin100%Part D≥15 patientsOpioid Agonist1.5%Tramadol Hcl61%Oxycodone Hcl39%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
10 NIH research awards on record, funded 1985–2001 per NIH RePORTER. The latest:
- NON-OPIOID DYNA:MOLECULAR/CELLULAR/PHYSIOLOGICAL STUDIES
California Pacific Med Ctr Res Institute
FY2001$364,986P01DA011470 - CHARACTERIZATION AND REGULATION OF BETA-ENDORPHIN RECEPT
California Pacific Med Ctr Res Institute
FY2001$329,544R37DA002643 - Non-opioid dynorphin A restores morphine synergy in tolerant animals
California Pacific Med Ctr Res Institute
FY2001P01DA011470
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”